- 2023 - 2026 Large-scale cross-ancestry multi-omics study to elucidate the pathogenesis of COVID-19 severity and Long COVID
- 2022 - 2025 Novel therapeutic strategy for refractory asthma using immunophenotyping
- 2017 - 2022 Field survey on Impact of living environments on brain, cardiovascular, respiratory and locomotive system, and co-benefit evaluation of disease and long-term care prevention
- 2018 - 2021 Elucidation of severe asthma associated with obesity using human gut bacteria transplanted mice
- 2016 - 2018 Identification of phenotypes of eosinophils in eosinophilic inflammation using multi-omics analysis
- 2014 - 2017 steroid resistance of upper and lower airways
- 2014 - 2017 Elucidation of the role of IL-23 in bronchial asthma caused by skin barrier dysfunction and drug discovery application
- 2013 - 2016 Metabolomics-based molecular phenotyping of severe asthma
- 2014 - 2015 難治性喘息における抗炎症性脂質メディエーターの治療応用への可能性
- 2010 - 2012 The efficacy and role ofanti-lipid mediators on pulmonary fibrosis
- 2009 - 2011 Immunomodulatory role of PGD2/CRTH2 pathway in the pathophysiology of refractory lung diseases
- 2007 - 2008 Prostaglandin D2 and its receptors in the pathogenesis of refractory inflammatory pulmonary diseases
- 2006 - 2008 The role and effect of anti-inflammatory lipid mediator, lipoxin on aspiration pneumonia
Show all